Avitar, Inc. Avitar, Inc.

Avitar, Inc.

AVTI

Rank in Stocks #35247
Avitar, Inc., through its subsidiaries, designs, develops, manufactures, and... Avitar, Inc., through its subsidiaries, designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine, such as crack; marijuana; and methamphetamines, including meth and ecstasy. The company also provides foam disposable products, including medical-grade hydrophilic polyurethane foam disposables, such as wound dressings comprising Hydrasorb, a wound dressing product for exudating wounds; and various custom foam products comprising a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. In addition, it develops specialty wound dressings for the cardiac catheter lab market and the Illizarov Dressing used for dressing external bone fixators in orthopedic procedures. The company markets its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies, schools, and corporations through direct sales force and strategic partners, as well as through a network of distributors. Avitar, Inc. was founded in 1986 and is based in Canton, Massachusetts.
Share Price
$0.00001
Last synced: 2026-11-20
Market Cap
$8.69
Change (1 day)
0.00%
Change (1 year)
0.00%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for Avitar, Inc. (AVTI)
Operating Margin as of November 2026 TTM: 87.98%
According to Avitar, Inc.'s latest financial reports, its current operating margin (TTM) is 87.98%. At the end of 2007 the company had an operating margin of 87.98%.
Operating Margin history for Avitar, Inc. from 2000 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 87.98% 0.00%
2007 87.98% 36.78%
2006 64.32% -24.23%
2005 84.89% 30.66%
2004 64.97% -6.73%
2003 69.66% 59.62%
2002 43.64% -52.74%
2001 92.35% -40.72%
2000 155.79% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
18.94% -99.78%
IE
10.95% -99.88%
CN
30.43% -99.65%
CH
13.54% -99.85%
CH
38.62% -99.56%
CN
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Avitar, Inc.'s operating margin

What is Avitar, Inc.'s operating margin?

Avitar, Inc.'s operating margin is 87.98%, as of Nov 2026.

What was Avitar, Inc.'s operating margin in 2007?

In 2007, Avitar, Inc.'s operating margin was 87.98%, compared with 64.32% in 2006.

How has Avitar, Inc.'s operating margin changed since 2002?

From 2002 to 2007, Avitar, Inc.'s operating margin was highest in 2007 (87.98%) and lowest in 2002 (43.64%).

How does Avitar, Inc.'s operating margin compare with similar companies?

Avitar, Inc.'s operating margin (87.98%) is higher than that of all 5 similar companies listed above. The highest among them is Jafron Biomedical Co.,Ltd., with 38.62%.